Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Mayo Clinic Laboratories Mayo Clinic United States | 5 | 5 |
|
Institute of Human Genetics Justus-Liebig University Germany | 1 | 1 |
|
Spinocerebellar Ataxia Panel (SCA1,2,3,6, and 7) Center for Genetics at Saint Francis Saint Francis Hospital United States | 5 | 5 |
|
SCA Panel (SCA1, 2, 3, 6, 7) test Neurogenetics Cyprus Institute of Neurology and Genetics Cyprus | 5 | 5 |
|
Ataxin 1 (ATXN1) gene CAG triplet repeat test Neurogenetics Cyprus Institute of Neurology and Genetics Cyprus | 1 | 1 |
|
ATXN1 - Repeat expansion analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Centogene AG - the Rare Disease Company Germany | 13 | 13 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Genomic UnityⓇ Ataxia Repeat Expansion Analysis (STR analysis of 16 loci) Variantyx, Inc. United States | 15 | 13 |
|
Genomic UnityⓇ Comprehensive Ataxia Analysis (includes STR analysis of 16 loci) Variantyx, Inc. United States | 52 | 53 |
|
qGenEx Intellectual disability Quantitative Genomic Medicine Laboratories, SL Spain | 3 | 1969 |
|
Spinocerebellar ataxia type 1 presymptomatic testing Genetics Service Unit BRIC-National Institute of Biomedical Genomics India | 1 | 1 |
|
Genetic Services Laboratory University of Chicago United States | 14 | 14 |
|
Genetic Services Laboratory University of Chicago United States | 294 | 481 |
|
Molecular Diagnostic Laboratory Diagnostic Services, Shared Health Manitoba Canada | 1 | 1 |
|
Movement diseases (WES based NGS panel of 931 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 10 | 930 |
|
Spinocerebellar ataxia 1 (SCA1, CAG expansion on ATXN1 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
CGC Genetics Unilabs Portugal | 1 | 5 |
|
CGC Genetics Unilabs Portugal | 1 | 10 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.